Calliditas Therapeutics AB (Calliditas Therapeutics AB) Days Payable

: 332.91 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

Calliditas Therapeutics AB's average Accounts Payable for the three months ended in Dec. 2023 was $7.93 Mil. Calliditas Therapeutics AB's Cost of Goods Sold for the three months ended in Dec. 2023 was $2.17 Mil. Hence, Calliditas Therapeutics AB's Days Payable for the three months ended in Dec. 2023 was 332.91.

The historical rank and industry rank for Calliditas Therapeutics AB's Days Payable or its related term are showing as below:

CALT' s Days Payable Range Over the Past 10 Years
Min: 709.94 Med: 1764.76 Max: 2741.82
Current: 709.94

During the past 9 years, Calliditas Therapeutics AB's highest Days Payable was 2741.82. The lowest was 709.94. And the median was 1764.76.

CALT's Days Payable is ranked better than
81.23% of 714 companies
in the Biotechnology industry
Industry Median: 151.205 vs CALT: 709.94

Calliditas Therapeutics AB's Days Payable declined from Sep. 2022 (1,948.86) to Dec. 2023 (332.91). It may suggest that Calliditas Therapeutics AB accelerated paying its suppliers.

Calliditas Therapeutics AB Days Payable Historical Data

The historical data trend for Calliditas Therapeutics AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calliditas Therapeutics AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

2,856.97

782.01

Calliditas Therapeutics AB Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Days Payable																1,948.86	1,456.69	765.43	432.12	332.91

Competitive Comparison

For the Biotechnology subindustry, Calliditas Therapeutics AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Calliditas Therapeutics AB Days Payable Distribution

For the Biotechnology industry and Healthcare sector, Calliditas Therapeutics AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Calliditas Therapeutics AB's Days Payable falls into.

Calliditas Therapeutics AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Calliditas Therapeutics AB's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (15.456	+	9.804)	/	2 )	/	5.895	*	365
=	12.63					/	5.895	*	365
=	782.01

Calliditas Therapeutics AB's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (6.059	+	9.804)	/	2 )	/	2.174	*	365 / 4
=	7.9315					/	2.174	*	365 / 4
=	332.91

Calliditas Therapeutics AB Days Payable Related Terms

Thank you for viewing the detailed overview of Calliditas Therapeutics AB's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Calliditas Therapeutics AB (Calliditas Therapeutics AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calliditas Therapeutics AB (NAS:CALT) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

CALTX:Sweden CALTXs:UK LC8:Germany

Address

Kungsbron 1, D5, Stockholm, SWE, SE-111 22

Website

https://www.calliditas.se

Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with unmet medical needs. The company's pipeline candidate is TARPEYO medication to reduce proteinuria in IgA nephropathy.